Pancreatic and hepatobiliary cancers: New treatment possibilities for pancreatic and biliary tumours

This publication has 21 references indexed in Scilit:

• Current chemotherapeutic possibilities in pancreaticobiliary cancer
  Annals of Oncology, 1999
• Experimental drugs and drug combinations in pancreatic cancer
  Annals of Oncology, 1999
• An investigational new drug treatment program for patients with gemcitabine
  Cancer, 1999
• Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors
  Annals of Oncology, 1998
• A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors
  Investigational New Drugs, 1997
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
  Journal of Clinical Oncology, 1997
• Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma
  Annals of Oncology, 1996
• Phase II study of gemcitabine in patients with advanced pancreatic cancer
  British Journal of Cancer, 1996
• Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
  Investigational New Drugs, 1994
• A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin
  Cancer, 1990